Invesco Ltd. Novo Cure LTD Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Invesco Ltd. holds 75,774 shares of NVCR stock, worth $857,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,774

Previous 90,277 16.06%

Holding current value

$857,761

Previous $1.61 Million 39.04%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$10.9 - $18.46 $158,082 - $267,725	-14,503 Reduced 16.06%	75,774 $979,000
Q2 2025 Aug 13, 2025	SELL	$15.37 - $19.4 $173,219 - $218,637	-11,270 Reduced 11.1%	90,277 $1.61 Million
Q1 2025 May 12, 2025	SELL	$17.82 - $30.19 $1.57 Million - $2.65 Million	-87,927 Reduced 46.41%	101,547 $1.81 Million
Q4 2024 Feb 13, 2025	BUY	$14.54 - $33.41 $1.16 Million - $2.66 Million	79,698 Added 72.6%	189,474 $5.65 Million
Q3 2024 Nov 12, 2024	SELL	$15.61 - $23.34 $1,810 - $2,707	-116 Reduced 0.11%	109,776 $1.72 Million

Q2 2024 Aug 13, 2024	SELL	$11.83 - $24.05 $369,616 - $751,418	-31,244 Reduced 22.14%	109,892 $1.88 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $447,318 - $622,716	36,016 Added 34.26%	141,136 $2.21 Million
Q4 2023 Feb 12, 2024	SELL	$11.13 - $15.78 $894,774 - $1.27 Million	-80,393 Reduced 43.34%	105,120 $1.57 Million
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $491,541 - $1.29 Million	30,436 Added 19.63%	185,513 $3 Million
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $133,964 - $274,345	3,325 Added 2.19%	155,077 $6.44 Million
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $86,409 - $181,898	1,531 Added 1.02%	151,752 $9.13 Million
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $4.36 Million - $5.81 Million	68,087 Added 82.9%	150,221 $11 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $280,186 - $369,117	-4,121 Reduced 4.78%	82,134 $6.24 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $901,468 - $1.43 Million	15,927 Added 22.65%	86,255 $5.99 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $600,657 - $844,016	9,986 Added 16.55%	70,328 $5.83 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $6.54 Million - $10.6 Million	-87,160 Reduced 59.09%	60,342 $4.53 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $11.3 Million - $18.9 Million	-97,242 Reduced 39.73%	147,502 $17.1 Million
Q2 2021 Aug 17, 2021	BUY	$130.4 - $225.58 $15.6 Million - $27 Million	119,829 Added 95.93%	244,744 $54.3 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $7.35 Million - $11.3 Million	59,185 Added 90.04%	124,915 $16.5 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $5.54 Million - $8.6 Million	49,380 Added 302.02%	65,730 $11.4 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $628,623 - $1.21 Million	-10,829 Reduced 39.84%	16,350 $1.82 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $38 Million - $49.4 Million	-663,478 Reduced 96.06%	27,179 $1.61 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $15.4 Million - $25.9 Million	-270,565 Reduced 28.15%	690,657 $46.5 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $27.2 Million - $37.3 Million	397,564 Added 70.53%	961,222 $81 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $2.21 Million - $3.5 Million	-35,779 Reduced 5.97%	563,658 $42.2 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $9.43 Million - $14.1 Million	223,352 Added 59.39%	599,437 $37.9 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $5.3 Million - $9.31 Million	165,815 Added 78.86%	376,085 $18.1 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $6.04 Million - $11.1 Million	210,270 New	210,270 $7.04 Million

Others Institutions Holding NVCR

# of Institutions

291

Shares Held

74.2M

Call Options Held

1.26M

Put Options Held

247K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account